Barixen 2 mg (Tablet)
Unit Price: ৳ 25.00 (2 x 10: ৳ 500.00)
Strip Price: ৳ 250.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Baricitinib |
| Company | Everest pharmaceuticals ltd |
Indications
- Treatment of adult patients with moderate to severely active Rheumatoid Arthritis
- Inadequate response to one or more tumor necrosis factor (TNF) antagonist therapies
Pharmacology
- Selective and reversible inhibitor of Janus kinase JAK1 and JAK2
- Transduction of intracellular signals from cell surface receptors
- Inhibition of enzymatic activity of JAK1 and JAK2
- Reduction of phosphorylation and activation of STATs
Dosage & Administration
- Recommended adult dose: 2 mg once daily
- May be used as monotherapy or in combination with Methotrexate or other Disease-modifying antirheumatic drugs (DMARDS)
- Oral administration with or without food
- Not established for pediatric use
- Dose selection caution for geriatric use
- No dose adjustment in patients with mild or moderate hepatic impairment
- Not recommended for use in patients with estimated GFR of less than 60 mL/min/I .73 m2
Interaction
- Increased exposure when co-administered with strong OAT3 inhibitors (e.g., probenecid)
- Not studied in combination with other JAK inhibitors or biologic DMARDS
Contraindications
- Avoid initiation or interrupt in patients with hemoglobin less than 8 g/dL
- Avoid initiation or interrupt in patients with an Absolute Lymphocyte Count less than 500 cells/mm3
- Avoid initiation or interrupt in patients with an Absolute Neutrophil Count less than 1000 cells/mm3
Side Effects
- Commonly reported adverse drug reactions: increased LDL cholesterol, upper respiratory tract infections, and nausea
Pregnancy & Lactation
- Contraindicated during pregnancy
- No available information on the presence of Baricitinib in human milk
Precautions & Warnings
- Avoid use in patients with an active, serious infection, including localized infections
- Not recommended for patients with active TB
- Consider risks and benefits prior to initiating therapy in patients with a known malignancy
- Use with caution in patients who may be at increased risk of thrombosis
- Use with caution in patients who may be at increased risk for gastrointestinal perforation
- To be dispensed only by the prescription of a registered physician
Overdose Effects
- Monitoring for signs and symptoms of adverse reactions recommended in case of an overdose
- Patients who develop adverse reactions should receive appropriate treatment
Therapeutic Class
- Immunosuppressant
Storage Conditions
- Store at or below 30°C temperature
- Keep away from light and wet place
- Keep out of reach of children